Histopathological vascular investigation of the peritumoral brain zone of glioblastomas

Ryota Tamura, Kentaro Ohara, Hikaru Sasaki, Yukina Morimoto, Kazunari Yoshida, Masahiro Toda

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

To date, no histopathological vascular investigation focusing on peritumoral brain zone (PBZ) has been reported for glioblastoma. We analyzed 10 newly diagnosed cases of glioblastomas. For these PBZs, histopathological investigation was performed by hematoxylin–eosin (H&E) staining and immunohistochemistry was analyzed for CD31, CD34, Factor VIII, VEGF, VEGFR-1/2, Ki67, p53 and nestin. Although it was difficult to identify PBZ by H&E, Ki67 and p53 staining, there were apparent differences in nestin staining among PBZ, tumor core (TC), and normal zone (NZ). Therefore, in this study, we divided PBZ from TC and NZ by nestin staining. Differences in histological features, microvessel density, expression of VEGF and its receptors were assessed for PBZ, TC and NZ. The microvessel density, as determined by counting CD31, CD34 and VEGF receptors, and VEGF-A expression were lower in PBZ than TC. The expression patterns for CD31, CD34 and VEGF receptors in vessels show dissociation in PBZ. In addition, the vascular characteristics of the PBZ may correlate with findings of radiographic imaging. We provide the first clinicopathological evidence that PBZ exhibits unique angiogenic characteristics. These in situ observations will help to elucidate the mechanisms of tumor recurrence.

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalJournal of Neuro-Oncology
DOIs
Publication statusAccepted/In press - 2017 Nov 29

Fingerprint

Glioblastoma
Blood Vessels
Brain Neoplasms
Nestin
Vascular Endothelial Growth Factor Receptor
Staining and Labeling
Brain
Microvessels
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factor Receptor-1
Vascular Endothelial Growth Factor Receptor-2
Factor VIII
Immunohistochemistry
Recurrence
Neoplasms

Keywords

  • CD34
  • Nestin
  • Peritumoral
  • VEGF-A
  • VEGFR

ASJC Scopus subject areas

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Cite this

Histopathological vascular investigation of the peritumoral brain zone of glioblastomas. / Tamura, Ryota; Ohara, Kentaro; Sasaki, Hikaru; Morimoto, Yukina; Yoshida, Kazunari; Toda, Masahiro.

In: Journal of Neuro-Oncology, 29.11.2017, p. 1-9.

Research output: Contribution to journalArticle

@article{74727199da1442308910c5c62bb40a7e,
title = "Histopathological vascular investigation of the peritumoral brain zone of glioblastomas",
abstract = "To date, no histopathological vascular investigation focusing on peritumoral brain zone (PBZ) has been reported for glioblastoma. We analyzed 10 newly diagnosed cases of glioblastomas. For these PBZs, histopathological investigation was performed by hematoxylin–eosin (H&E) staining and immunohistochemistry was analyzed for CD31, CD34, Factor VIII, VEGF, VEGFR-1/2, Ki67, p53 and nestin. Although it was difficult to identify PBZ by H&E, Ki67 and p53 staining, there were apparent differences in nestin staining among PBZ, tumor core (TC), and normal zone (NZ). Therefore, in this study, we divided PBZ from TC and NZ by nestin staining. Differences in histological features, microvessel density, expression of VEGF and its receptors were assessed for PBZ, TC and NZ. The microvessel density, as determined by counting CD31, CD34 and VEGF receptors, and VEGF-A expression were lower in PBZ than TC. The expression patterns for CD31, CD34 and VEGF receptors in vessels show dissociation in PBZ. In addition, the vascular characteristics of the PBZ may correlate with findings of radiographic imaging. We provide the first clinicopathological evidence that PBZ exhibits unique angiogenic characteristics. These in situ observations will help to elucidate the mechanisms of tumor recurrence.",
keywords = "CD34, Nestin, Peritumoral, VEGF-A, VEGFR",
author = "Ryota Tamura and Kentaro Ohara and Hikaru Sasaki and Yukina Morimoto and Kazunari Yoshida and Masahiro Toda",
year = "2017",
month = "11",
day = "29",
doi = "10.1007/s11060-017-2648-9",
language = "English",
pages = "1--9",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",

}

TY - JOUR

T1 - Histopathological vascular investigation of the peritumoral brain zone of glioblastomas

AU - Tamura, Ryota

AU - Ohara, Kentaro

AU - Sasaki, Hikaru

AU - Morimoto, Yukina

AU - Yoshida, Kazunari

AU - Toda, Masahiro

PY - 2017/11/29

Y1 - 2017/11/29

N2 - To date, no histopathological vascular investigation focusing on peritumoral brain zone (PBZ) has been reported for glioblastoma. We analyzed 10 newly diagnosed cases of glioblastomas. For these PBZs, histopathological investigation was performed by hematoxylin–eosin (H&E) staining and immunohistochemistry was analyzed for CD31, CD34, Factor VIII, VEGF, VEGFR-1/2, Ki67, p53 and nestin. Although it was difficult to identify PBZ by H&E, Ki67 and p53 staining, there were apparent differences in nestin staining among PBZ, tumor core (TC), and normal zone (NZ). Therefore, in this study, we divided PBZ from TC and NZ by nestin staining. Differences in histological features, microvessel density, expression of VEGF and its receptors were assessed for PBZ, TC and NZ. The microvessel density, as determined by counting CD31, CD34 and VEGF receptors, and VEGF-A expression were lower in PBZ than TC. The expression patterns for CD31, CD34 and VEGF receptors in vessels show dissociation in PBZ. In addition, the vascular characteristics of the PBZ may correlate with findings of radiographic imaging. We provide the first clinicopathological evidence that PBZ exhibits unique angiogenic characteristics. These in situ observations will help to elucidate the mechanisms of tumor recurrence.

AB - To date, no histopathological vascular investigation focusing on peritumoral brain zone (PBZ) has been reported for glioblastoma. We analyzed 10 newly diagnosed cases of glioblastomas. For these PBZs, histopathological investigation was performed by hematoxylin–eosin (H&E) staining and immunohistochemistry was analyzed for CD31, CD34, Factor VIII, VEGF, VEGFR-1/2, Ki67, p53 and nestin. Although it was difficult to identify PBZ by H&E, Ki67 and p53 staining, there were apparent differences in nestin staining among PBZ, tumor core (TC), and normal zone (NZ). Therefore, in this study, we divided PBZ from TC and NZ by nestin staining. Differences in histological features, microvessel density, expression of VEGF and its receptors were assessed for PBZ, TC and NZ. The microvessel density, as determined by counting CD31, CD34 and VEGF receptors, and VEGF-A expression were lower in PBZ than TC. The expression patterns for CD31, CD34 and VEGF receptors in vessels show dissociation in PBZ. In addition, the vascular characteristics of the PBZ may correlate with findings of radiographic imaging. We provide the first clinicopathological evidence that PBZ exhibits unique angiogenic characteristics. These in situ observations will help to elucidate the mechanisms of tumor recurrence.

KW - CD34

KW - Nestin

KW - Peritumoral

KW - VEGF-A

KW - VEGFR

UR - http://www.scopus.com/inward/record.url?scp=85035356318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035356318&partnerID=8YFLogxK

U2 - 10.1007/s11060-017-2648-9

DO - 10.1007/s11060-017-2648-9

M3 - Article

C2 - 29188530

AN - SCOPUS:85035356318

SP - 1

EP - 9

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

ER -